BioNTech
BNTX
282 hedge funds and large institutions have $4.34B invested in BioNTech in 2023 Q4 according to their latest regulatory filings, with 70 funds opening new positions, 91 increasing their positions, 70 reducing their positions, and 38 closing their positions.
84% more first-time investments, than exits
New positions opened: 70 | Existing positions closed: 38
30% more repeat investments, than reductions
Existing positions increased: 91 | Existing positions reduced: 70
12% more funds holding
Funds holding: 252 → 282 (+30)
8% more capital invested
Capital invested by funds: $4.01B → $4.34B (+$330M)
1.92% more ownership
Funds ownership: 15.42% → 17.33% (+1.9%)
5% more call options, than puts
Call options by funds: $234M | Put options by funds: $224M
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HL
Harding Loevner
Bridgewater,
New Jersey
|
+$397M |
| 2 |
Morgan Stanley
New York
|
+$68.1M |
| 3 |
Squarepoint
New York
|
+$29.3M |
| 4 |
Amundi
Paris,
France
|
+$22.4M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$13.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$67.6M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
-$37.9M |
| 3 |
Millennium Management
New York
|
-$33.5M |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$21.7M |
| 5 |
CGI
Comgest Global Investors
Paris,
France
|
-$20.4M |
BNTX Hedge Fund Activity: Q4 2023 in Review
282 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in BioNTech (BNTX) for Q4 2023, worth a combined $4.34B — up 8.2% from $4.01B a quarter earlier.
Buyers outnumbered sellers: 70 funds opened new BNTX positions and 38 closed out — a net gain of 32 holders — while 91 added to existing stakes and 70 trimmed.
The largest buyer was Harding Loevner, opening a new position worth an estimated $397M. The largest seller was Artisan Partners, cutting an estimated $67.6M.
- 282 institutional investors held BioNTech (BNTX) as of Q4 2023, up from 252 in Q3 2023.
- Funds reported $4.34B of BioNTech stock for Q4 2023, up 8.2% quarter-over-quarter.
- 70 funds opened new BioNTech positions in Q4 2023 and 38 closed out, a net change of +32 holders.
- The largest BioNTech buyer in Q4 2023 was Harding Loevner, an estimated $397M added.
- The largest BioNTech seller in Q4 2023 was Artisan Partners, an estimated $67.6M sold.
Based on aggregated 13F filings for Q4 2023.